Healthcare
Live Price
Offline$1.43
-7.77% today
1Y Change
+4.22%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
So-Young International Inc. (SY) is a Healthcare stock with a market cap of $2.70B and listed on NASDAQ. The stock last traded around $1.43 and up 4.2% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +1.0%, EPS growth of +59.6%, a dividend yield of 0.0%. What stands out right now is revenue +1.0%, EPS +59.6%, free cash flow -242.5% with operating margin -17.5% and ROIC -13.4%. Valuation is more restrained than many high-expectation growth names at price/sales 1.8. Stock Foundry combines SY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SY Max Drawdown
-70.53%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.7B
+34.5% YoY
FY Net Income
-$8.4M
+87.2% YoY
Free Cash Flow
$142.2M
+262.5% YoY
Revenue Growth
+1.0%
EPS Growth
+59.6%
Gross Margin
47.8%
Net Margin
-15.9%
Income statement
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.5B | 1.5B | 1.3B | 1.7B |
| Gross Profit | 708M | 899M | 954M | 865M | 1.4B |
| Operating Income | -259M | -624M | -61M | -103M | -33M |
| EBITDA | -259M | -38M | -15M | -56M | 63M |
| Net Income | -236M | -590M | 21M | -66M | -8M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CNY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 483M | 588M | 426M | 694M | 1.3B |
| Total Assets | 2.7B | 2.7B | 3.2B | 3.2B | 3.3B |
| Total Liabilities | 981M | 776M | 653M | 590M | 813M |
| Shareholder Equity | 1.6B | 1.8B | 2.4B | 2.5B | 2.4B |
| Total Debt | 300M | 240M | 146M | 71M | 106M |
| Net Debt | -183M | -348M | -280M | -623M | -1.2B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
179M
+112.6% YoY
Capital Expenditures
37M
+18.0% YoY
Free Cash Flow
142M
+262.5% YoY
Key ratios
Gross Margin
47.8%
Operating Margin
-17.5%
Net Margin
-15.9%
ROE
-14.3%
Debt / Equity
0.19x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.